StockNews.com began coverage on shares of InVivo Therapeutics (NASDAQ:NVIV – Get Free Report) in a research report issued to clients and investors on Monday. The firm set a “sell” rating on the biotechnology company’s stock. InVivo Therapeutics Price Performance Shares of NASDAQ NVIV opened at $1.20 on Monday. InVivo Therapeutics has a 52 week low […]
StockNews.com started coverage on shares of InVivo Therapeutics (NASDAQ:NVIV – Free Report) in a research report released on Sunday. The firm issued a sell rating on the biotechnology company’s stock. InVivo Therapeutics Stock Up 2.3 % Shares of NASDAQ NVIV opened at $1.19 on Friday. InVivo Therapeutics has a twelve month low of $0.81 and […]
StockNews.com assumed coverage on shares of InVivo Therapeutics (NASDAQ:NVIV – Free Report) in a research note released on Friday. The firm issued a sell rating on the biotechnology company’s stock. InVivo Therapeutics Stock Performance Shares of NVIV stock opened at $1.37 on Friday. InVivo Therapeutics has a 52-week low of $0.81 and a 52-week high […]
StockNews.com initiated coverage on shares of InVivo Therapeutics (NASDAQ:NVIV – Free Report) in a report issued on Friday. The firm issued a sell rating on the biotechnology company’s stock. InVivo Therapeutics Stock Performance NASDAQ:NVIV traded down $0.03 during mid-day trading on Friday, hitting $1.34. 12,093 shares of the stock traded hands, compared to its average […]
StockNews.com began coverage on shares of InVivo Therapeutics (NASDAQ:NVIV – Free Report) in a research report report published on Monday morning. The brokerage issued a sell rating on the biotechnology company’s stock. InVivo Therapeutics Price Performance Shares of InVivo Therapeutics stock opened at $1.33 on Monday. The business has a 50 day simple moving average […]